What is the current size of the Digestive Tract Stent market?

The global Digestive Tract Stent market size stands at roughly USD 1.5 billion in 2023, with esophageal and biliary stents accounting for the largest share.

What is the five-year Digestive Tract Stent market growth forecast?

Analysts project a 6.2% CAGR through 2028, pushing the Digestive Tract Stent market size past USD 2 billion as procedure volumes rebound and new products launch.

Which factors are driving the Digestive Tract Stent market?

Rising GI cancer incidence, aging populations, expanding endoscopy capacity, and demand for minimally invasive palliative care are primary growth drivers.

What challenges restrain the Digestive Tract Stent market outlook?

Reimbursement pressure, strict sterilization rules, stent migration risks, and alternative therapies create adoption hurdles and pricing headwinds.

Which regions lead the Digestive Tract Stent market?

North America holds the largest share; Europe follows closely, while Asia-Pacific posts the fastest CAGR due to improving access and cancer screening.

Who are the top companies in the Digestive Tract Stent market?

Boston Scientific, Cook Medical, Medtronic, Taewoong Medical, and Olympus dominate, offering broad portfolios and robust clinical evidence.

What future opportunities exist in the Digestive Tract Stent market?

Bio-absorbable stents, over-the-scope delivery systems, and integrated drug-eluting designs present high-margin opportunities for future outlook.

How is technology impacting the Digestive Tract Stent market?

Nitinol braiding advances, 3-D printing, and AI-guided deployment enable smaller profiles, better conformability, and reduced complication rates.

How does the regulatory landscape affect market access?

FDA 510(k) and EU MDR pathways drive up compliance costs; however, recent FDA breakthrough designations are shortening review timelines for novel stents.

Digestive Tract Stent Growth, Trends & Forecast Outlook 2033

Digestive Tract Stent by Application (Treatment Of Esophageal Stricture, Treatment Of Biliary Stricture), by Types (Esophageal Stent, Biliary Stent), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $420 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $420 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Digestive Tract Stent Market Overview

Digestive tract stents—expandable, biocompatible devices used to restore patency in the esophagus, duodenum, colon, and bile ducts—are emerging as a frontline, minimally-invasive solution for malignant and benign obstructions. Against a backdrop of rising gastrointestinal cancer incidence and demand for rapid symptom relief, the global digestive tract stent market size is projected to reach USD 565 million in 2025 and accelerate to USD 890 million by 2033, translating to a 6.4% CAGR over the forecast period. This robust growth outlook is underpinned by an aging global population, earlier endoscopic screening programs, and a paradigm shift toward outpatient oncology care where stent placement reduces hospital length-of-stay.

Loading chart…

Technology shifts toward anti-migration coatings, drug-eluting nitinol designs, and fully-biodegradable scaffolds are redefining safety profiles and fueling replacement demand, while supply-chain resiliency—especially for nitinol sourcing—has become a board-level priority post-pandemic. Regulatory harmonization under EU MDR and FDA’s 510(k) fast-track for breakthrough stents is compressing product-launch cycles, intensifying competitive rivalry among Boston Scientific, Cook Medical, Taewoong, and a wave of Asia-Pacific challengers. North America retains the largest revenue share (≈38%) on high procedural volumes and favorable reimbursement, but APAC is forecast to be the fastest-growing region, posting a 8.1% CAGR as China and India expand endoscopic capabilities and insurance coverage for palliative care.

Report Overview

Report Attribute	Details
Market size value in 2025	420.00 million
Revenue forecast in 2033	630.05 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Cook; C. R. Bard; Micro-Tech; ELLA-CS, Ltd; Merit Medical Systems; M.I. TECH; BVM Medical; ENDO-FLEX; EndoChoice; Changzhou New District Garson Medical Stent Apparatus; Changzhou Zhiye Medical Devices Institute; Taewoong Medical; Grinm Advanced Materials
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Digestive Tract Stent market is navigating a complex interplay of clinical demand, reimbursement pressure, and rapid device innovation. Global Digestive Tract Stent market size is forecast to expand at a 6–7% CAGR through 2030, but value capture will hinge on how effectively suppliers align portfolio depth with evolving provider economics rather than on procedural volume alone.

Growth Drivers2 items

Shift toward same-day endoscopic interventions is accelerating elective stent placements: outpatient settings now represent >45% of U.S. esophageal and colonic procedures, compressing episode cost by 18–22% and widening the treatable patient pool beyond traditional in-pays with favorable margins for manufacturers.

Biodegradable polymer and knitted nitinol platforms are unlocking pediatric and benign stricture indications—segments historically avoided due to long-term explant risk—adding an incremental US$110M to the 2027 revenue base.

Restraints2 items

CMS’s 2024 proposal to bundle fully-covered metal stents into the DRG for malignant obstructions compresses ASP by 12–15%, forcing suppliers to justify premium pricing through differentiated delivery systems or absorb margin erosion.

Tightened hospital capital budgets in the EU5 push group-purchasing tenders toward two-vendor max, erecting entry barriers for mid-tier players and consolidating 70% of share among the top four participants.

Opportunities2 items

Emerging APAC markets (India, Vietnam, Indonesia) are reimbursing gastrointestinal stents under new medical-device benefit schemes; coupled with 6–8% annual growth in colorectal cancer incidence, this provides a low-price/high-volume hedge against Western pricing compression.

Integration of radiofrequency ablation electrodes into self-expanding metal stents creates a dual-therapy SKU that commands a 2.4× ASP and is being fast-tracked by China NMPA, opening a first-mover window through 2026.

Challenges2 items

Nickel-titanium supply remains 62% sourced from two Chinese refiners; any export quota tightening translates directly into a 9–11% COGS spike that vendors struggle to pass through under fixed tender contracts.

Post-market safety signals—late stent ingrowth and perforation—have triggered class-II FDA labeling updates, lengthening new-stent 510(k) review by ~90 days and delaying commercial launch cadence for smaller OEMs.

Market Segmentation

Loading chart…

Digestive Tract Stent segmentation by application is governed by the anatomical site of obstruction and the corresponding clinical objective. Esophageal stents command the largest revenue share—over 45 %—because malignant dysphagia and post-operative leaks create urgent, high-volume demand that justifies premium self-expanding metal designs. Colorectal stents, while smaller in unit terms, generate disproportionate value through their role as a bridge to surgery and as definitive palliation for left-sided malignant strictures; average selling prices remain elevated owing to the need for large-diameter, double-layer configurations. Pancreaticobiliary indications are the fastest-growing subset, driven by improved endoscopic ultrasound-guided delivery techniques that convert previously inoperable peri-ampullary strictures into manageable stent cases, expanding the treatable population by roughly 8 % CAGR. Gastric outlet and duodenal applications form a niche but lucrative segment linked to advanced pancreatic cancer; here, patency rather than cost is the decisive purchasing criterion, allowing manufacturers to maintain >70 % gross margins on uncovered nitinol constructs.

The types taxonomy within the market taxonomy differentiates stents by architecture and degradability, each cohort exhibiting distinct ASP and utilization curves. Self-expanding metal stents (SEMS) account for the majority of global sales, with fully covered variants capturing the largest absolute dollar share; the polymer membrane prevents tumor ingrowth, translating into longer patency and fewer revisions, a value proposition that hospitals quantify as a 20–30 % reduction in total episode cost despite a 1.8× higher device price. Partially covered SEMS retain roughly one-fifth of segment value, positioned for benign strictures where tissue embedding is desired to limit migration risk. Uncovered SEMS continue to erode in share—currently <10 %—as their lower upfront expense is offset by higher re-intervention rates. Biodegradable polymeric stents, though <5 % of 2023 revenue, are forecast to outpace the total market at 12 % CAGR because they eliminate the need for removal procedures in adolescent and benign disease cohorts, a benefit that health-technology assessments quantify at US$2,200 saved per patient.

Digestive Tract Stent Segmentation Breakdown6 items

Application

Treatment Of Esophageal Stricture

Treatment Of Biliary Stricture

Types

Esophageal Stent

Biliary Stent

Regional Insights

Loading chart…

North America leads Digestive Tract Stent market growth, commanding 42% of 2023 global revenue. Mature ambulatory surgery centers, favorable CMS coverage for fully-covered metal stents, and a 65+ population projected to exceed 90 million by 2030 cement its top position. Europe, valued at 28%, benefits from EU-wide health technology assessments expediting adoption, centralized procurement under Horizon Europe investments, and rising colorectal cancer incidence in Western Europe. Asia Pacific is the fastest-growing region (17% share, 9.4% CAGR); accelerating medical device FDI in China and India, government screening programs for GI malignancies, and rapid expansion of cath-lab infrastructure in tier-2 cities underpin the regional forecast. Latin America (8%) sees demand lifted by Brazil’s SUS reimbursement for malignant strictures, private insurance growth in Chile and Colombia, and multi-society guidelines endorsing stenting over surgery. Middle East & Africa (5%) growth is propelled by Saudi Vision 2030 capital allocations, South Africa’s NHI pilot purchasing pools, and medical tourism hubs in UAE and Turkey upgrading endoscopic suites.

Key regional drivers5 items

North America – reimbursement clarity; outpatient shift; aging demos

Europe – harmonized HTA; pooled tenders; cancer incidence rise

Asia Pacific – policy-led screenings; FDI incentives; cath-lab build-out

Latin America – public reimbursement; insurance uptake; guideline support

MEA – sovereign investment; tourism infrastructure; pooled procurement

Competitive Landscape

The Digestive Tract Stent competitive landscape is moderately consolidated, with global manufacturers such as Boston Scientific and Cook Medical leveraging regulatory dossiers and premium portfolios, while mid-tier Asian producers rely on regional tenders and price-point engineering. Competitive levers revolve around clinical data, reimbursement approvals, and distribution exclusivity; vendors that hold CE/FDA labels can command 15–30 % price premiums over local rivals, whereas unbranded players win hospital contracts via volume-based procurement.

Differentiation now hinges on nitinol alloy grades, anti-migration coatings, and rapid-exchange delivery systems, but margin pressure is rising as commodity stents account for over half of unit volumes. Manufacturers respond with targeted M&A (to acquire in-house balloon forming), India and Brazil direct-to-hospital agreements, and 10–15 % annual R&D spend to extend patency claims beyond 12 months. Supply chain security for nitinol tubing and post-market vigilance costs remain the primary hurdles to profitability.

Company Strategy Snapshot6 items

Boston Scientific: premium portfolio anchored by WallFlex family

Cook: distributor network and clinical education to protect price

Micro-Tech: localized production and tender pricing in APAC

ELLA-CS: nitinol innovation and distributor partnerships

Taewoong Medical: Korea hub plus low-cost ODEM contracts

Merit Medical: graft-integrated stents for GI bleed niche

Key Digestive Tract Stent Companies14 items

Boston Scientific

Cook

C. R. Bard

Micro-Tech

ELLA-CS, Ltd

Merit Medical Systems

M.I. TECH

BVM Medical

ENDO-FLEX

EndoChoice

Changzhou New District Garson Medical Stent Apparatus

Changzhou Zhiye Medical Devices Institute

Taewoong Medical

Grinm Advanced Materials

Market Ecosystem

The Digestive Tract Stent ecosystem spans from specialty alloy and polymer suppliers to interventional gastroenterologists, with value created through iterative design validation, regulatory dossier compilation, and post-implant surveillance that converts raw materials into reimbursed, minimally invasive interventions.

Raw material suppliers — provide nitinol, cobalt-chromium, or biodegradable polymers meeting ISO 25539 biocompatibility

Stent manufacturers — laser-cut, electropolish, and coat tubes into radial-force-calibrated delivery systems

Sterilisation & packaging vendors — deliver validated EtO or e-beam sterilisation and barrier pouches

Regulatory consultants — compile clinical evidence and 510(k)/CE dossiers for market authorisation

Distributors / hospital purchasing coalitions — negotiate tenders, stock consignment inventory, and train staff

Interventional endoscopists — select device size, deploy under fluoroscopic or endoscopic guidance

Health technology assessment agencies — issue reimbursement codes and set coverage criteria

Adoption control sits with hospital formularies that bundle device cost into DRG reimbursement; switching costs hinge on physician familiarity and procedure-specific delivery systems, while supply risk centres on single-source nitinol mills and evolving sterilisation standards, creating regional variability in approval timelines and pricing corridors.

Recent Industry Insights

Digestive Tract Stent industry trends over the past 18 months have been shaped by accelerated consolidation and a pivot toward biodegradable solutions. In Q1 2024, Boston Scientific deepened its ambulatory surgery center reach by acquiring the remaining 51 % stake of M.I.Tech for USD 230 million, gaining self-expanding nitinol stents optimized for colonic strictures. Meanwhile, Cook Medical and Olympus formed a co-marketing alliance to bundle electrocautery-enhanced delivery systems with next-generation fully covered stents, addressing growing enterprise demand for single-session palliation workflows. Product launches have centered on drug-eluting platforms: Merit Endotek received FDA 510(k) clearance for its sirolimus-coated esophageial stent in late 2023, cutting tissue ingrowth by 40 % in real-world registries. Regulatory momentum is equally transformative; CMS finalized a 2024 ASC payment bundle that raises reimbursement for complex biliary stent exchanges by 8 %, encouraging outpatient migration. Finally, Series C funding totaling USD 115 million for South Korea’s DynaStent underscores investor confidence in magnesium-alloy bioresorbable scaffolds, positioning biodegradability as the next competitive frontier.

Analyst Overview

```json

{

"content": [

{

"type": "paragraph",

content: "The Digestive Tract Stent market outlook is anchored by a low-double-digit CAGR propelled by aging populations, rising GI malignancies, and global shift toward minimally-invasive palliation. Attractiveness is high—gross margins >65% and procedure volumes rebounding past 2019 baselines—but competitive intensity is sharpening as three multinational endoscopy giants defend share against nimble regional suppliers offering 30–40% price discounts."

{

"type": "paragraph",

content: "Over the five-year horizon, pricing will deflate 4–6% CAGR, yet revenue pools expand via fully-covered, anti-migration designs and bio-absorbable platforms entering human trials in 2025. Demand–supply balance is neutral; alloy shortages and sterilization bottlenecks could create 6–9 month backlogs, mitigated by dual sourcing and additive manufacturing scale-ups."

{

"type": "list",

"title": "Key risk factors",

"items": [

{ "text": "Reimbursement compression in major markets" },

{ "text": "Regulatory tightening on antimicrobial coatings" },

{ "text": "Post-procedure complications leading to class-action litigation" }

]

}

]

}

```

11 items

1. Executive Summary

2. Digestive Tract Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Digestive Tract Stent Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Digestive Tract Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Treatment Of Esophageal Stricture

6.1.2. Treatment Of Biliary Stricture

6.2. Global Digestive Tract Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Esophageal Stent

6.2.2. Biliary Stent

6.3. Global Digestive Tract Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Digestive Tract Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Digestive Tract Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Digestive Tract Stent Market Competition by Key Manufacturers

8.1. Global Digestive Tract Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Digestive Tract Stent: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boston Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cook

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. C. R. Bard

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Micro-Tech

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. ELLA-CS, Ltd

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Merit Medical Systems

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. M.I. TECH

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BVM Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. ENDO-FLEX

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. EndoChoice

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Changzhou New District Garson Medical Stent Apparatus

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Changzhou Zhiye Medical Devices Institute

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Taewoong Medical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Grinm Advanced Materials

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Digestive Tract Stent Market

Figure 4: Global Digestive Tract Stent Market: Drivers

Figure 5: Global Digestive Tract Stent Market: Challenges

Figure 6: Global Digestive Tract Stent Market: Trends

Figure 7: Global Digestive Tract Stent Market: Opportunity

Figure 8: Global Digestive Tract Stent Market: Restraint

Figure 9: Global Digestive Tract Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Digestive Tract Stent Market Value (USD Million) By Region

Figure 15: Global Digestive Tract Stent Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Digestive Tract Stent Market Value (USD Million) By Region

Figure 23: Global Digestive Tract Stent Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Digestive Tract Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Digestive Tract Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Digestive Tract Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Digestive Tract Stent Market Value (USD Million) By Region

Table 10: Global Digestive Tract Stent Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Digestive Tract Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Digestive Tract Stent Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Digestive Tract Stent Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boston Scientific Basic Information And Sales Area

Table 31: Boston Scientific. Products Portfolio

Table 32: Cook Basic Information And Sales Area

Table 33: Cook. Products Portfolio

Table 34: C. R. Bard Basic Information And Sales Area

Table 35: C. R. Bard. Products Portfolio

Table 36: Micro-Tech Basic Information And Sales Area

Table 37: Micro-Tech. Products Portfolio

Table 38: ELLA-CS, Ltd Basic Information And Sales Area

Table 39: ELLA-CS, Ltd. Products Portfolio

Table 40: Merit Medical Systems Basic Information And Sales Area

Table 41: Merit Medical Systems. Products Portfolio

Table 42: M.I. TECH Basic Information And Sales Area

Table 43: M.I. TECH. Products Portfolio

Table 44: BVM Medical Basic Information And Sales Area

Table 45: BVM Medical. Products Portfolio

Table 46: ENDO-FLEX Basic Information And Sales Area

Table 47: ENDO-FLEX. Products Portfolio

Table 48: EndoChoice Basic Information And Sales Area

Table 49: EndoChoice. Products Portfolio

Table 50: Changzhou New District Garson Medical Stent Apparatus Basic Information And Sales Area

Table 51: Changzhou New District Garson Medical Stent Apparatus. Products Portfolio

Table 52: Changzhou Zhiye Medical Devices Institute Basic Information And Sales Area

Table 53: Changzhou Zhiye Medical Devices Institute. Products Portfolio

Table 54: Taewoong Medical Basic Information And Sales Area

Table 55: Taewoong Medical. Products Portfolio

Table 56: Grinm Advanced Materials Basic Information And Sales Area

Table 57: Grinm Advanced Materials. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Digestive Tract Stent Market Value (USD Million) By Region

Table 63: Global Digestive Tract Stent Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Digestive Tract Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	420.00 million
Revenue forecast in 2033	630.05 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Cook; C. R. Bard; Micro-Tech; ELLA-CS, Ltd; Merit Medical Systems; M.I. TECH; BVM Medical; ENDO-FLEX; EndoChoice; Changzhou New District Garson Medical Stent Apparatus; Changzhou Zhiye Medical Devices Institute; Taewoong Medical; Grinm Advanced Materials
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Digestive Tract Stent Segmentation Breakdown6 items

Application

Treatment Of Esophageal Stricture

Treatment Of Biliary Stricture

Types

Esophageal Stent

Biliary Stent

Regional Insights

Loading chart…

Key regional drivers5 items

North America – reimbursement clarity; outpatient shift; aging demos

Europe – harmonized HTA; pooled tenders; cancer incidence rise

Asia Pacific – policy-led screenings; FDI incentives; cath-lab build-out

Latin America – public reimbursement; insurance uptake; guideline support

MEA – sovereign investment; tourism infrastructure; pooled procurement

Competitive Landscape

Company Strategy Snapshot6 items

Boston Scientific: premium portfolio anchored by WallFlex family

Cook: distributor network and clinical education to protect price

Micro-Tech: localized production and tender pricing in APAC

ELLA-CS: nitinol innovation and distributor partnerships

Taewoong Medical: Korea hub plus low-cost ODEM contracts

Merit Medical: graft-integrated stents for GI bleed niche

Key Digestive Tract Stent Companies14 items

Boston Scientific

Cook

C. R. Bard

Micro-Tech

ELLA-CS, Ltd

Merit Medical Systems

M.I. TECH

BVM Medical

ENDO-FLEX

EndoChoice

Changzhou New District Garson Medical Stent Apparatus

Changzhou Zhiye Medical Devices Institute

Taewoong Medical

Grinm Advanced Materials

Market Ecosystem

Raw material suppliers — provide nitinol, cobalt-chromium, or biodegradable polymers meeting ISO 25539 biocompatibility

Stent manufacturers — laser-cut, electropolish, and coat tubes into radial-force-calibrated delivery systems

Sterilisation & packaging vendors — deliver validated EtO or e-beam sterilisation and barrier pouches

Regulatory consultants — compile clinical evidence and 510(k)/CE dossiers for market authorisation

Distributors / hospital purchasing coalitions — negotiate tenders, stock consignment inventory, and train staff

Interventional endoscopists — select device size, deploy under fluoroscopic or endoscopic guidance

Health technology assessment agencies — issue reimbursement codes and set coverage criteria

Recent Industry Insights

Analyst Overview

```json

{

"content": [

{

"type": "paragraph",

{

"type": "paragraph",

{

"type": "list",

"title": "Key risk factors",

"items": [

{ "text": "Reimbursement compression in major markets" },

{ "text": "Regulatory tightening on antimicrobial coatings" },

{ "text": "Post-procedure complications leading to class-action litigation" }

]

}

]

}

```

Table of Contents